Literature DB >> 16133028

Preliminary results after implantation of four AlphaCor artificial corneas.

H Bleckmann1, S Holak.   

Abstract

PURPOSE: The purpose was to evaluate the validity of implantation of the artificial cornea (AlphaCor) in human corneas considered too high risk for penetrating keratoplasty with donor tissue.
METHODS: Four keratoprostheses, made from poly(2-hydroxyethyl methacrylate) (PHEMA) with a porous skirt and a transparent optical part, were implanted into the cornea of four patients. Keratocytes invading the skirt provide a watertight fixation with the scarred corneal tissue. Deep to the clear optical part, the posterior corneal lamella was excised to a diameter of 3.5 mm before the device was implanted, and the anterior lamella was trephined similarly 3 months after AlphaCor implantation.
RESULTS: The eyes selected to receive an artificial cornea had significant neovascularisation, and 0-3 previous failed grafts. Follow-up for 6 months revealed best visual acuity between 20/400 and 20/50. Factors limiting the visual acuity outcome were optic atrophy and age-related macular disease. One patient underwent an extracapsular cataract extraction after the device was implanted, as a senile cataract was then noted. One complication occurred, a central corneal stromal melt, which was managed by covering with a 9-mm donor lamella.
CONCLUSION: The flexible device AlphaCor may provide a substitute for donor corneal tissue in desperate cases. Advantages include the simple implantation technique, which avoids trauma to the surrounding structures. Visual acuity results may be limited by pre-existing pathology, but it appears that a patient's visual potential can be achieved. Further follow-up to exclude long-term complications is required.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133028     DOI: 10.1007/s00417-005-0068-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Development and clinical assessment of an artificial cornea.

Authors:  C Hicks; G Crawford; T Chirila; S Wiffen; S Vijayasekaran; X Lou; J Fitton; M Maley; A Clayton; P Dalton; S Platten; B Ziegelaar; Y Hong; A Russo; I Constable
Journal:  Prog Retin Eye Res       Date:  2000-03       Impact factor: 21.198

2.  Surface modification of silicone rubber membrane by plasma induced graft copolymerization as artificial cornea.

Authors:  G H Hsiue; S D Lee; P C Chang
Journal:  Artif Organs       Date:  1996-11       Impact factor: 3.094

Review 3.  Keratoprostheses: advancing toward a true artificial cornea.

Authors:  C R Hicks; J H Fitton; T V Chirila; G J Crawford; I J Constable
Journal:  Surv Ophthalmol       Date:  1997 Sep-Oct       Impact factor: 6.048

4.  [2nd generation bio-integrated keratoprosthesis. Implantation in animals].

Authors:  J M Legeais; I Drubaix; B Briat; G Renard; Y Pouliquen
Journal:  J Fr Ophtalmol       Date:  1997       Impact factor: 0.818

5.  Improvement of the osteo-odonto-keratoprosthesis according to Strampelli: influence of diameter of PMMA cylinder on visual field.

Authors:  K Hille; H Landau; K W Ruprecht
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-04       Impact factor: 3.117

6.  Development of a biopolymeric keratoprosthetic material. Evaluation in vitro and in vivo.

Authors:  V Trinkaus-Randall; J Capecchi; A Newton; A Vadasz; H Leibowitz; C Franzblau
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-03       Impact factor: 4.799

7.  Detection of glaucomatous damage in patients with osteo-odontokeratoprosthesis.

Authors:  G C Falcinelli; B Falsini; M Taloni; M Piccardi; G Falcinelli
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

8.  Cell viability and inflammatory response in hydrogel sponges implanted in the rabbit cornea.

Authors:  S Vijayasekaran; J H Fitton; C R Hicks; T V Chirila; G J Crawford; I J Constable
Journal:  Biomaterials       Date:  1998-12       Impact factor: 12.479

9.  Deposits in artificial corneas: risk factors and prevention.

Authors:  Celia R Hicks; Traian V Chirila; Liliana Werner; Geoffrey J Crawford; David J Apple; Ian J Constable
Journal:  Clin Exp Ophthalmol       Date:  2004-04       Impact factor: 4.207

10.  Cataract surgery with the AlphaCor artificial cornea.

Authors:  Hiroshi Eguchi; Celia R Hicks; Geoffrey J Crawford; Donald T Tan; Gerard R Sutton
Journal:  J Cataract Refract Surg       Date:  2004-07       Impact factor: 3.351

View more
  4 in total

1.  Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model.

Authors:  D Karamichos; A E K Hutcheon; J D Zieske
Journal:  J Tissue Eng Regen Med       Date:  2011-05-23       Impact factor: 3.963

2.  AlphaCor keratoprosthesis: postoperative development of six patients.

Authors:  S A Holak; H M Holak; H Bleckmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-22       Impact factor: 3.117

3.  Evaluation of stability and biocompatibility of PHEMA-PMMA keratoprosthesis by penetrating keratoplasty in rabbits.

Authors:  Yawon Hwang; Gonhyung Kim
Journal:  Lab Anim Res       Date:  2016-12-23

4.  In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas.

Authors:  Shuji Sasaki; Seiichi Funamoto; Yoshihide Hashimoto; Tsuyoshi Kimura; Takako Honda; Shinya Hattori; Hisatoshi Kobayashi; Akio Kishida; Manabu Mochizuki
Journal:  Mol Vis       Date:  2009-10-13       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.